Historical Valuation
Clearpoint Neuro Inc (CLPT) is now in the Undervalued zone, suggesting that its current forward PS ratio of 8.36 is considered Undervalued compared with the five-year average of -17.71. The fair price of Clearpoint Neuro Inc (CLPT) is between 54.74 to 72.53 according to relative valuation methord. Compared to the current price of 15.31 USD , Clearpoint Neuro Inc is Undervalued By 72.03%.
Relative Value
Fair Zone
54.74-72.53
Current Price：15.31
72.03%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Clearpoint Neuro Inc (CLPT) has a current Price-to-Book (P/B) ratio of 25.13. Compared to its 3-year average P/B ratio of 11.61 , the current P/B ratio is approximately 116.35% higher. Relative to its 5-year average P/B ratio of 16.38, the current P/B ratio is about 53.37% higher. Clearpoint Neuro Inc (CLPT) has a Forward Free Cash Flow (FCF) yield of approximately -3.31%. Compared to its 3-year average FCF yield of -6.29%, the current FCF yield is approximately -47.34% lower. Relative to its 5-year average FCF yield of -5.53% , the current FCF yield is about -40.08% lower.
P/B
Median3y
11.61
Median5y
16.38
FCF Yield
Median3y
-6.29
Median5y
-5.53
Competitors Valuation Multiple
AI Analysis for CLPT
The average P/S ratio for CLPT competitors is 111.81, providing a benchmark for relative valuation. Clearpoint Neuro Inc Corp (CLPT.O) exhibits a P/S ratio of 8.36, which is -92.53% above the industry average. Given its robust revenue growth of 9.10%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for CLPT
1Y
3Y
5Y
Market capitalization of CLPT increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of CLPT in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is CLPT currently overvalued or undervalued?
Clearpoint Neuro Inc (CLPT) is now in the Undervalued zone, suggesting that its current forward PS ratio of 8.36 is considered Undervalued compared with the five-year average of -17.71. The fair price of Clearpoint Neuro Inc (CLPT) is between 54.74 to 72.53 according to relative valuation methord. Compared to the current price of 15.31 USD , Clearpoint Neuro Inc is Undervalued By 72.03% .
What is Clearpoint Neuro Inc (CLPT) fair value?
CLPT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Clearpoint Neuro Inc (CLPT) is between 54.74 to 72.53 according to relative valuation methord.
How does CLPT's valuation metrics compare to the industry average?
The average P/S ratio for CLPT's competitors is 111.81, providing a benchmark for relative valuation. Clearpoint Neuro Inc Corp (CLPT) exhibits a P/S ratio of 8.36, which is -92.53% above the industry average. Given its robust revenue growth of 9.10%, this premium appears unsustainable.
What is the current P/B ratio for Clearpoint Neuro Inc (CLPT) as of Jan 09 2026?
As of Jan 09 2026, Clearpoint Neuro Inc (CLPT) has a P/B ratio of 25.13. This indicates that the market values CLPT at 25.13 times its book value.
What is the current FCF Yield for Clearpoint Neuro Inc (CLPT) as of Jan 09 2026?
As of Jan 09 2026, Clearpoint Neuro Inc (CLPT) has a FCF Yield of -3.31%. This means that for every dollar of Clearpoint Neuro Inc’s market capitalization, the company generates -3.31 cents in free cash flow.
What is the current Forward P/E ratio for Clearpoint Neuro Inc (CLPT) as of Jan 09 2026?
As of Jan 09 2026, Clearpoint Neuro Inc (CLPT) has a Forward P/E ratio of -16.90. This means the market is willing to pay $-16.90 for every dollar of Clearpoint Neuro Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Clearpoint Neuro Inc (CLPT) as of Jan 09 2026?
As of Jan 09 2026, Clearpoint Neuro Inc (CLPT) has a Forward P/S ratio of 8.36. This means the market is valuing CLPT at $8.36 for every dollar of expected revenue over the next 12 months.